Streptococcus pneumoniae surface protein PcpA elicits protection against lung infection and fatal sepsis
about
Choline Binding Proteins from Streptococcus pneumoniae: A Dual Role as Enzybiotics and Targets for the Design of New AntimicrobialsNonencapsulated Streptococcus pneumoniae: Emergence and PathogenesisDiagnosis of pneumococcal pneumonia: current pitfalls and the way forwardThe role of zinc in the interplay between pathogenic streptococci and their hostsGenome analysis of a highly virulent serotype 1 strain of Streptococcus pneumoniae from West AfricaThe host immune dynamics of pneumococcal colonization: implications for novel vaccine developmentVirulence potential and genome-wide characterization of drug resistant Streptococcus pneumoniae clones selected in vivo by the 7-valent pneumococcal conjugate vaccineHighly Variable Streptococcus oralis Strains Are Common among Viridans Streptococci Isolated from PrimatesIntraclonal variations among Streptococcus pneumoniae isolates influence the likelihood of invasive disease in children.Panel 6: Vaccines.T(H)17-based vaccine design for prevention of Streptococcus pneumoniae colonizationStreptococcus pneumoniae clonal complex 199: genetic diversity and tissue-specific virulenceOptions for inactivation, adjuvant, and route of topical administration of a killed, unencapsulated pneumococcal whole-cell vaccine.Contributions to protection from Streptococcus pneumoniae infection using the monovalent recombinant protein vaccine candidates PcpA, PhtD, and PlyD1 in an infant murine model during challengeStreptococcus pneumoniae in biofilms are unable to cause invasive disease due to altered virulence determinant production.PsrP, a protective pneumococcal antigen, is highly prevalent in children with pneumonia and is strongly associated with clonal typeNon-typeable pneumococci circulating in Portugal are of cps type NCC2 and have genomic features typical of encapsulated isolates.Prevalence and clonal distribution of pcpA, psrP and Pilus-1 among pediatric isolates of Streptococcus pneumoniae.Preclinical evaluation of the Pht proteins as potential cross-protective pneumococcal vaccine antigens.Human antibodies to PhtD, PcpA, and Ply reduce adherence to human lung epithelial cells and murine nasopharyngeal colonization by Streptococcus pneumoniae.Identification of potential new protein vaccine candidates through pan-surfomic analysis of pneumococcal clinical isolates from adults.Evaluation of a vaccine formulation against Streptococcus pneumoniae based on choline-binding proteins.Next generation pneumococcal vaccinesSerum antibody response to five Streptococcus pneumoniae proteins during acute otitis media in otitis-prone and non-otitis-prone childrenGenetic diversity of the Pneumococcal CbpA: Implications for next-generation vaccine development.Synchrony in serum antibody response to conserved proteins of Streptococcus pneumoniae in young children.Higher levels of mucosal antibody to pneumococcal vaccine candidate proteins are associated with reduced acute otitis media caused by Streptococcus pneumoniae in young children.PspA family distribution, unlike capsular serotype, remains unaltered following introduction of the heptavalent pneumococcal conjugate vaccine.Transcriptional and metabolic effects of glucose on Streptococcus pneumoniae sugar metabolism.Immunization with Pneumococcal Surface Protein K of Nonencapsulated Streptococcus pneumoniae Provides Protection in a Mouse Model of Colonization.PcpA Promotes Higher Levels of Infection and Modulates Recruitment of Myeloid-Derived Suppressor Cells during Pneumococcal Pneumonia.Antibody response to Streptococcus pneumoniae proteins PhtD, LytB, PcpA, PhtE and Ply after nasopharyngeal colonization and acute otitis media in children.Microbial interactions during upper respiratory tract infectionsNext generation protein based Streptococcus pneumoniae vaccinesEfficacy of opsonic and nonopsonic serotype 3 pneumococcal capsular polysaccharide-specific monoclonal antibodies against intranasal challenge with Streptococcus pneumoniae in mice.CD4+ T-cell responses among adults and young children in response to Streptococcus pneumoniae and Haemophilus influenzae vaccine candidate protein antigens.Asthma and antibodies to pneumococcal virulence proteins.Protection against Pneumococcal colonization and fatal pneumonia by a trivalent conjugate of a fusion protein with the cell wall polysaccharide.CD4 T cell memory and antibody responses directed against the pneumococcal histidine triad proteins PhtD and PhtE following nasopharyngeal colonization and immunization and their role in protection against pneumococcal colonization in mice.Rationale and prospects for novel pneumococcal vaccines.
P2860
Q26744448-5184EC38-D3CF-42EA-9955-33766988E433Q26752517-4D5D4DC9-17AB-4D7A-A438-09BDEC171219Q26865184-6DED1D0A-A954-47D3-AC19-ED6492D75C35Q27003448-EAD6FEDC-F317-44A7-ACB6-2C97E74285ACQ27315098-18CEAB90-D43B-476D-8B55-E1E941A38A0BQ28084920-0EFB2D0D-4B75-4942-940B-108F9BDF0D23Q28533656-893E75ED-10E5-4046-B62C-AD81847581D8Q28834430-F4655C11-9DDA-4390-86FB-75EF4CC70058Q33585361-E2F77AB0-29D9-43D6-A3F4-4499445A72B7Q33644678-A84B178F-9A1E-49F9-BB32-D5757672DFD0Q33820413-6979AEAE-5963-4BCB-9957-4FCF7C7F226CQ33886611-AD675A81-6773-4F67-A28F-79824F31E0D0Q33909187-35560464-8A0C-4649-A986-B80ECAB6E30CQ34057765-53D6CBA8-0D58-4D80-8224-D52ADA435A3CQ34103322-3A4E7616-CD63-4C7A-BC2E-C6328B0781A9Q34289805-973B1641-D15C-483F-B884-C4E24855B700Q34355264-817F47E6-A634-496B-AAAF-B874D52137D6Q34358647-CCCB613D-C974-4A42-BD25-EE20D507203AQ34484575-EC1A206C-0C19-4EAC-87F4-A64A60DD9C72Q34595710-02B893D0-3A3D-4EF9-A7E0-833AC7EA007DQ34876231-A612B032-9D96-43BD-9403-E46187249697Q35021099-0E262097-0D33-4B1F-9351-09B50C5369E6Q35028495-63829059-B6F8-4F0D-AD6B-68FD7B81A520Q35811715-C438FE65-D18F-4705-BD6C-622C41832219Q35886867-20B39FD8-02A6-4D6E-94BF-0C46C2BAB9EAQ35887453-9B6D32FD-D9F0-42EF-B307-057F053B557AQ35915846-A0AADD30-0D36-441F-8AA1-E0CAB072FE7FQ36017785-7AF6C3A9-8D75-43AF-B78F-487BCD40E648Q36128987-4C44EC39-B4B8-4B85-BE07-59BB01E0BFF6Q36211630-05C26BD9-EFAC-4903-955D-B5AF0EB2C2AEQ36600946-B2D83D18-5970-4ED9-8B40-CF9D717CE8DEQ36920037-B6BDD94D-E58B-4655-9BF1-E6B6F2829FB7Q37028479-75C6E2DB-D066-47AC-AFB2-5163EA4F6740Q37130191-1733878E-6ACA-4572-8E60-0A2561A8FE65Q37145037-63F4C2CC-AA4C-4E06-9F81-CF068D990FA9Q37184360-ADCB1142-C70F-4BAB-A28E-E79C0F16B08CQ37185085-B0A92AF1-AEE2-4705-9CD7-038943372704Q37191236-835C75B2-7AF6-4184-8374-0BD05233A349Q37264678-1C4072C4-D0E8-433A-99EB-400EA2D15356Q37309218-8A0D6223-F3F5-46C5-BF5F-20C5F729BA2F
P2860
Streptococcus pneumoniae surface protein PcpA elicits protection against lung infection and fatal sepsis
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
2008年论文
@zh
2008年论文
@zh-cn
name
Streptococcus pneumoniae surfa ...... ung infection and fatal sepsis
@en
Streptococcus pneumoniae surfa ...... ng infection and fatal sepsis.
@nl
type
label
Streptococcus pneumoniae surfa ...... ung infection and fatal sepsis
@en
Streptococcus pneumoniae surfa ...... ng infection and fatal sepsis.
@nl
prefLabel
Streptococcus pneumoniae surfa ...... ung infection and fatal sepsis
@en
Streptococcus pneumoniae surfa ...... ng infection and fatal sepsis.
@nl
P2093
P2860
P356
P1476
Streptococcus pneumoniae surfa ...... ung infection and fatal sepsis
@en
P2093
David E Briles
David T Glover
Susan K Hollingshead
P2860
P304
P356
10.1128/IAI.01126-07
P407
P577
2008-04-07T00:00:00Z